Hello, my name is Antonia and I’m the new intern in the ISB group. My research project is about the dietary effects on acute and chronic inflammation in the human liver, and also how exercise and muscle growth is affected by switching diets. The state of the liver is strongly associated with both physical activity and your dietary habits, therefore it’s quite relevant to look at these two factors and how they could affect the liver. My focus will be on the switching from an omnivore to a strict plant-based diet. Since I’m vegan myself, I thought it would be interesting to do a project that is connected to my lifestyle. I’m planning on working on this project throughout the whole year and I’m excited to see how it goes!
New internship student – Antonia
Uncategorised Posted on Fri, October 04, 2019 14:30:17- Comments(0) https://blog.isbgroup.eu/?p=100
Medicinteknikdagarna
Uncategorised Posted on Tue, October 01, 2019 16:39:42This week we are going to Medicinteknikdagarna – a conference for medical engineering here in Linköping (at Konsert & kongress). We have a presentation on Wednesday 13:30 and we have two posters. We will also be present in the LiU monter. The poster session and LiU monter is open for the public. Hope to see you there!
Info about the conference: https://www.mtf.nu/event/medicinteknikdagarna-2019/
- Comments(0) https://blog.isbgroup.eu/?p=98
Precise4Q meeting in Dublin
Uncategorised Posted on Tue, October 01, 2019 16:36:52This May, I (Tilda) was in Dublin for meetings with the Precise4q consortium. Check out the project here: https://precise4q.eu/. We presented our progress and discussed the coming EU review in Luxembourg this December. Next meeting will be here in Linköping this November. Stay tuned!
- Comments(0) https://blog.isbgroup.eu/?p=96
What makes a modelling work Science? Its ability to describe data!
Systems biology and science Posted on Mon, March 04, 2019 00:51:15In my work as a scientist, one of the possible tasks I can take upon
myself is to be a reviewer. This is important, but almost completely
non-valued; there is no pay, and no funding agency cares very much whether you do it or not. However, the review process is the most important place where scientific
discussions are taking place, because currently – and unfortunately –
this is virtually the only criteria for what constitutes a scientific finding
today: has it been published in a peer-reviewed journal? I therefore do
spend some time doing this. And I fight a lot of the time with papers
and authors who want to publish mathematical modelling works without any
comparison with experimental data. I strongly believe that such works
are not science, and that they should not be published. Today, I just
submitted such a response, and since the reply is written in a
completely non-specific manner to the paper in question – it could have
been written to any paper with the same problem – I also post it here.
My principle for the the next decade of my life, which I just entered,
is “going public, going deep”, and this publishing of this here on the blog, is a
part of me following that new principle.
Here is the review reply that I wrote:
“Thank you for your comments.
I do recognize the fact that you and others have published similar
papers in the past, where models have been developed and presented with
no comparison with data. There is nothing I can do about that. However,
that fact does not transform such works into science. Modern science is,
in my very firm opinion, the truth-seeking tool that was established by
Galileo, many hundreds of years ago: it builds on i) the mathematical
formalization of mechanistic hypotheses of the system that you study,
and then ii) usage of *data* to distinguish between those hypotheses.
The hypothesis that has the best ability at describing data – in the
first round estimation data, and in the second round independent
validation data, based on predictions and *then* experiments – is the
superior hypothesis. It is this formula for truth-seeking that
distinguished the science that started with Galileo, and the
church-driven epistemology that ruled science before him (note that the
prior Aristotelian science worldview also involved mathematics, and
data, but not in the same hypothesis-testing manner). If Galileo’s
formula is not followed, it is not science. That a paper has been
published in a scientific journal does not make that work science. It
does mean, however, that that work *should not* have been published. The
only exception to that principle exists within the field of
mathematics, which has other criteria for its judgements of a paper:
e.g. that what is presented should be i) previously non-proven and ii)
should hold true for a large family of equations/examples. Another type
of paper in mathematics can be that of a new method, e.g. for
optimization, that is proven to be superior to existing methods.
Unfortunately, this conception of what science is was lost in the field
of modelling of biological systems during a large part of the 20th
century. During this time, it was called mathematical biology,
complexity theory, etc. This was, to a large extent, rectified, during
the beginning of the 21st century, with the conception of systems
biology. However, unfortunately, much old-school data-free modelling is
still done. This has to stop! It is giving, and has been giving, the
field of modelling in biology a bad reputation, with the impression that
it has nothing to do with reality or biology – and rightly so, such
modelling has nothing to do with reality! At least not in any way that
has been demonstrated by science.
Two further clarifications and responses to your reply are in order:
i) You say that your model is based on data. That is true. The model structure is based on data. Your manuscript does
therefore function as a review of existing biology. But that is
something different than publishing an original research paper, with
novel results. That is something that is fundamentally different than
the kind of comparison between simulations of the *entire model
structure* and data that I am referring to above. It is a bit like
saying that the Ptolemaic worldview (with the sun in the middle) is
based on data because it includes the sun, the planets, and the earth;
which are observed in experiments. The question is not if they are
present. The question is which way of connecting them in relationship to
each other that is the correct one. To go beyond what can be said with
biology alone – i.e. to do mathematical modelling – requires that one
puts the structure together using competing hypotheses (e.g. one with
the sun in the middle, and one with the earth in the middle), and then
sees which of the two corresponding models that produces simulations
that best agrees with data (existing data and future data). That is how
science has functioned since Galileo, and that is how it should still
function today.
ii) You say that a model component
in your model – that has not been validated in any fashion whatsoever –
produces a prediction that a specific component is important; you then
also point to some papers that claim the same thing. That could, on
the surface, seem like a comparison with data. However, with the model
structure that you have put together – with the most well-known and most
often considered main players in the beta cell ethiology – you could
identify any component in your model as the most important one, and then
find many papers that claim that that component is the most important
one. That is, unfortunately, how biology is allowed to work today, with
many co-existing hypotheses, that are allowed to continue to co-exist,
where each lab focusing on one of the components is allowed to point to
limited results as to why their particular component is the most
important one, and without forcing anyone to challenge these claims with
respect to each other; without finding out what the big picture looks
like. That is where systems biology can and should come in and make a
difference: by putting up alternative hypotheses regarding what is the
most important component(s), and then letting data, systems-level data,
judge which of the hypotheses that is the most compelling one. This is
how systems biology has worked in many/most of the papers that are cited
in the review paper that I gave you. That way requires a model that
produces simulations (time-curves, typically), that agrees with
estimation data, and with validation data.
In summary, for me to
judge this or any paper as publishable, you need to produce (at least)
these two things: i) at least one curve, e.g. a simulation of a variable
as it progresses in time, that agrees with corresponding data; ii) a
prediction that is validated by another dataset, not used for estimating
the parameters in the model. In fact, apart from that you should also
demonstrate that your model is superior to other models, i.e. that it
can describe all data that one of the currently most important and
realistic models can, and then more data apart from that.
In
other words, there are many papers that are published for beta-cells,
including for their ethiology. These models can describe a lot of data,
in the above manner. Why not take one of those models, find a feature or
dataset that they cannot explain (there are many), and then go ahead
and improve the model to make it able to explain those data (while still
retaining the ability to explain all old data). If you then also show
that this is not due to overfitting w.r.t. all data, i.e. if you then
show that your new model also can describe some validation data, not
used for model fitting, then you will have contributed with an
improvement that follows the tradition of science. Then, and only then, I
will judge your – or any scientist’s – paper as publishable.
- Comments(0) https://blog.isbgroup.eu/?p=4
Ellen’s master thesis defence
Events Posted on Wed, January 23, 2019 14:53:04Today, Ellen
Lesshammar defended her master thesis project: ‘Mathematical modelling of TLR4-activated
macrophages in inflammation’. The project aimed to use a model-based approach to
investigate the synthesis and release of
cytokines from macrophages during inflammation and also when inflammatory
response is suppressed by anti-inflammatory drugs. The models Ellen constructed
have the potential of being further refined and extended to include other
aspects of inflammation and might thus hold the possibility to contribute to
the further understanding of inflammation and how it can be the root cause to
several common diseases.
The work was done here in the ISB-group but also at the
Linköping based company Wolfram MathCore. We would like to congratulate Ellen on a
job well done, and we wish her luck with all future endeavours!
- Comments(0) https://blog.isbgroup.eu/?p=5
Nicolas’s master thesis defence
Events Posted on Mon, December 03, 2018 14:56:21Nicolas’s master thesis
defence
Last week a member of our group held his master thesis defence. The
member in question was Nicolas who has been doing in his master thesis in our
group, as well as some work prior to that.
Nicolas hold a well-structured and informative presentation of his work
and defended his thesis in a great way.
Nicolas project aimed to characterize the metabolic fluxes of carbon-13
labelled metabolites throughout parts of the metabolic system. The fluxes were
determined from the structure of the metabolites in the end of the metabolic
system. By knowing the reactions in the system and the number of intermediate
products from the inserted labelled metabolites, one can determent the fluxes
between the reactions. This method is called metabolic flux analysis. Although
this is to hard math to do by hand, one can use mathematical modelling.
The second part of Nicolas project was to validate that his model could accurately
predict the quantities of the metabolic fluxes. However, today, there is no
established method for this kind of validation. Nicolas validated his model by the
model’s ability to predict a validation dataset, data that the model have not
seen before. By using this approach, one wish to see how the model react to new
data and judge the model quality by how true the model’s prediction of this
data is.
Additionally, the uncertainty of the predictions was analysed with a
profile likelihood analysis. With such predictions, one can place more trust in
fluxes determined by the model. Consequently, this allows for more challenging
issues to be tackled in the development process of new treatments.
With this we want to congratulate Nicolas on his completed master thesis
and wish good luck in the future.
- Comments(0) https://blog.isbgroup.eu/?p=6
New PhD student
News Posted on Wed, November 21, 2018 13:20:01Hello!
My name is Tilda and I have been in the isb
group before, but this November I started my phd here. I am financed by an EU
project called precise4Q. The project aims at personalising treatment of stroke
by developing model-based decision support systems. I will be working with combining
mechanistic multi-level models and machine learning models.
- Comments(0) https://blog.isbgroup.eu/?p=7
3th national diabetes summit
Events Posted on Wed, November 21, 2018 12:16:27On November 16th and 17th Gunnar, Elin, William, Tilda, Christian, Kajsa and Jonna attended the 3th national diabetes summit in Stockholm. During
this conference the Karolinska institute was the scene of many interesting conversations,
posters and presentations.
The program consisted of many interesting presentations
covering various aspects of diabetes research. Our group was represented with,
apart from a poster, a very nice talk by Elin. We have had many interesting conversations
with other researchers that may lead to some very nice collaborations. For me
personally the conference was a unique chance to see what kind of diabetes
research is performed in Sweden.
Since the end of November is approaching rapidly my time in
Sweden is almost coming to an end. I look back at a very nice time in Sweden were
I’ve learned a lot about modeling and applications of modeling to the liver.
And of course my new knowledge about things like Fika and warm meals during
lunch 😉
Regards, Jonna
- Comments(0) https://blog.isbgroup.eu/?p=8